<i>In Vivo</i> Growth of Mantle Cell Lymphoma Xenografts in Immunodeficient Mice Is Positively Regulated by VEGF and Associated with Significant Up-regulation of <i>CD31/PECAM1</i> Cited by

Fol. Biol. 2013, 59, 26-31

https://doi.org/10.14712/fb2013059010026

In Vivo Growth of Mantle Cell Lymphoma Xenografts in Immunodeficient Mice Is Positively Regulated by VEGF and Associated with Significant Up-regulation of CD31/PECAM1

Jan Molinský^1,2, M. Klánová^1,2, B. Maswabi², T. Soukup³, M. Trněný^1,4, E. Nečas², J. Živný², P. Klener^1,2

¹1st Department of Medicine – Department of Haematology, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic
²Institute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
³Department of Histology and Embryology, Medical Faculty in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic
⁴Institute of Haematology and Blood Transfusion, Prague, Czech Republic

Received October 2012
Accepted October 2012

Crossref Cited-by Linking

Vockova Petra, Molinsky Jan, Klanova Magdalena, Karban Josef, Spacek Martin, Havranek Ondrej, Kupcova Kristyna, Kazantsev Dmitry, Trneny Marek, Klener Pavel: CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement. Leukemia & Lymphoma 2021, 62, 861. <https://doi.org/10.1080/10428194.2020.1849678>
Nellore Anoma, Liu Bianling, Patsoukis Nikolaos, Boussiotis Vassiliki A., Li Lequn: The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectors. Clinical Immunology 2014, 152, 48. <https://doi.org/10.1016/j.clim.2014.02.015>